Suppr超能文献

肾微绒毛膜蛋白。莫能菌素、长春碱、苦马豆素和氨基葡萄糖对猪肾切片中内肽酶-24.11和二肽基肽酶IV加工与组装的影响。

Proteins of the kidney microvillar membrane. Effects of monensin, vinblastine, swainsonine and glucosamine on the processing and assembly of endopeptidase-24.11 and dipeptidyl peptidase IV in pig kidney slices.

作者信息

Stewart J R, Kenny A J

出版信息

Biochem J. 1984 Dec 1;224(2):559-68. doi: 10.1042/bj2240559.

Abstract

The effects of various inhibitors were studied on the biogenesis of endopeptidase-24.11 (EC 3.4.24.11) and dipeptidyl peptidase IV (EC 3.4.14.5) in slices of renal cortex, from piglets of the Yucatan strain, maintained in organ culture. These microvillar peptidases were synthesized within membrane compartments and underwent glycosylation to yield high-mannose and complex forms [the preceding paper, Stewart & Kenny (1984) Biochem. J. 224, 549-558]. Monensin caused very gross ultrastructural changes in the proximal-tubular cells, resulting from distension of the Golgi sacs. It blocked the processing of the high-mannose to the complex glycosylated forms of the peptidases and prevented their assembly in the microvillar membrane. Swainsonine, an inhibitor of alpha-mannosidase II, generated new 'hybrid' forms of the proteins, intermediate in Mr between the high-mannose and the complex forms, but did not prevent assembly of the hybrid forms in microvilli. Vinblastine, an agent that affects microtubules, delayed, but did not abolish, either the processing or the transport to microvilli. Glucosamine interfered with the initial glycosylation reactions and generated heterogeneous sets of partially glycosylated polypeptides of lower Mr than the high-mannose forms. These results are discussed in relation to the site and mechanism of glycosylation and the involvement of the Golgi complex and microtubules in the biogenesis of these membrane peptidases.

摘要

研究了多种抑制剂对尤卡坦品系仔猪肾皮质切片中内肽酶-24.11(EC 3.4.24.11)和二肽基肽酶IV(EC 3.4.14.5)生物合成的影响,肾皮质切片维持在器官培养中。这些微绒毛肽酶在膜隔室内合成,并进行糖基化以产生高甘露糖型和复合型[前文,Stewart和Kenny(1984年),《生物化学杂志》224卷,549 - 558页]。莫能菌素导致近端小管细胞出现非常明显的超微结构变化,这是由高尔基体囊泡扩张引起的。它阻断了肽酶从高甘露糖型向复合糖基化形式的加工过程,并阻止它们在微绒毛膜中组装。α-甘露糖苷酶II抑制剂苦马豆素产生了新的蛋白质“杂合”形式,其相对分子质量介于高甘露糖型和复合型之间,但并未阻止杂合形式在微绒毛中的组装。长春碱是一种影响微管的药物,它延迟了但并未消除加工过程或向微绒毛的转运。氨基葡萄糖干扰了初始糖基化反应,并产生了比高甘露糖型相对分子质量更低的部分糖基化多肽的异质集合。结合糖基化的位点和机制以及高尔基体复合体和微管在这些膜肽酶生物合成中的作用,对这些结果进行了讨论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/826c/1144465/951d95945fb2/biochemj00314-0219-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验